Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Monday's After-Market Session

Author: Benzinga Insights | August 18, 2025 05:06pm

Gainers

  • Wellgistics Health (NASDAQ:WGRX) shares rose 14.7% to $0.86 during Monday's after-market session. The market value of their outstanding shares is at $47.0 million.
  • Inhibikase Therapeutics (NASDAQ:IKT) stock moved upwards by 13.21% to $1.95. The market value of their outstanding shares is at $130.0 million. The company's, Q2 earnings came out 2 days ago.
  • DiaMedica Therapeutics (NASDAQ:DMAC) shares rose 9.2% to $6.29. The company's market cap stands at $311.6 million. The company's, Q2 earnings came out 4 days ago.
  • X4 Pharmaceuticals (NASDAQ:XFOR) shares moved upwards by 8.03% to $2.69. The market value of their outstanding shares is at $32.5 million.
  • ALT5 Sigma (NASDAQ:ALTS) stock moved upwards by 7.51% to $6.58. The company's market cap stands at $722.3 million.
  • Calidi Biotherapeutics (AMEX:CLDI) shares rose 7.31% to $4.4. The company's market cap stands at $18.1 million.

Losers

  • iBio (NASDAQ:IBIO) stock fell 17.2% to $0.61 during Monday's after-market session. The market value of their outstanding shares is at $12.0 million.
  • ALX Oncology Holdings (NASDAQ:ALXO) stock fell 15.82% to $0.82. The market value of their outstanding shares is at $34.5 million. As per the press release, Q2 earnings came out 4 days ago.
  • Propanc Biopharma (NASDAQ:PPCB) shares declined by 13.29% to $5.07. The market value of their outstanding shares is at $33.3 million.
  • Lixte Biotechnology (NASDAQ:LIXT) shares decreased by 10.99% to $3.4. The market value of their outstanding shares is at $16.3 million.
  • Soligenix (NASDAQ:SNGX) shares declined by 10.29% to $4.45. The company's market cap stands at $9.0 million. The company's, Q2 earnings came out 2 days ago.
  • Artelo Biosciences (NASDAQ:ARTL) stock decreased by 7.57% to $9.02. The market value of their outstanding shares is at $7.0 million. As per the news, the Q2 earnings report came out 3 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALTS ALXO ARTL CLDI DMAC IBIO IKT LIXT PPCB SNGX WGRX XFOR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist